HOME >> BIOLOGY >> NEWS
Highlights of American Chemical Society's national meeting in New Orleans

A "spice" that fights foodborne germs, vegetable oil for car engines, a vaccine to help smokers quit and chemical innovations to improve homeland security are among the topics to be covered at the national meeting of the world's largest scientific society in New Orleans, March 23-27.

NEW ORLEANS A record number of presentations, more than 8,500, are expected for the 225th national meeting of the American Chemical Society, the world's largest scientific society, in New Orleans, March 23-27. Research papers and posters will be presented at the Ernest N. Morial Convention Center, 900 Convention Center Boulevard, and surrounding hotels. The pressroom will be located in Room 280 of the convention center.

Highlights include:

  • Rechargeable batteries that operate on alcohol
  • Getting rid of termites with catnip
  • New class of nonaddictive painkillers that could be better than morphine
  • More efficient fridges and A/Cs with no moving parts
  • Contact lenses that dispense medicine
  • Cranberry juice increases levels of "good" cholesterol
  • Evolution of plants from sea to land: fossil evidence

News releases and advisories are posted on an embargoed basis, at www.eurekalert.org under the "ACS 225th National Meeting" button. They also will be posted at www.chemistry.org/news after the embargoes are lifted.

Sunday, March 23

Homeland security Advances in the development of sensors to detect chemical and biological warfare agents are among the topics that will be discussed during a one-day symposium entitled "Function-Based and Other Novel Approaches to Sensors for Homeland Defense." (ANYL 1-6, Sunday, March 9, 8:30 a.m.-11:40 a.m., Morial Convention Center, Room 384, and ANYL 13-
'"/>


26-Mar-2003


Page: 1 2 3 4 5

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
3. Highlights of the July Journal of the American Dietetic Association
4. Other Highlights in the June 2 JNCI
5. Highlights of Tufts University nutrition research: January 2004
6. Highlights of the November 2003 Journal of the American Dietetic Association
7. Highlights of the October 2003 Journal of the American Dietetic Association
8. Highlights of American Chemical Society meeting in New Orleans
9. Highlights of American Chemical Societys national meeting in Boston
10. Other Highlights in the July 3 Issue of JNCI
11. Quarterly News Tipsheet -- Research Highlights From Pacific Northwest National Laboratory

Post Your Comments:
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... Menlo Park, CA (PRWEB) December 17, 2014 ... Inc. announces today that it has entered into ... Daniels Midland Company (ADM) to apply DNA2.0’s proprietary ... industrial enzyme engineering process. , “We are extremely ... our ProteinGPS engineering platform. This proprietary bioengineering ...
(Date:12/17/2014)... 16, 2014  Vermillion, Inc. (NASDAQ: VRML ... today announced the next step in its expanded strategy ... provider with the naming of current Chief Operating Officer, ... Officer, while current Chairman of the Board and CEO ... Chairman. These changes are effective January 1, 2015. ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: